Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Zhang Turan Returns to London as SUNCUN Completes Four-City Fashion-Week Journey

September 30, 2026

Apeing Announces Stage 5 Presale Milestone as $APEING Sales Surpass 476 Million Tokens

September 30, 2026

China Unicom Europe Marks 20th Anniversary in London with AI and Mid-Autumn Showcase

September 30, 2026

281M $APEING Tokens Burned as Solana Pullback Draws Attention to Emerging Crypto Projects

September 30, 2026

A Century of Integration, Loyalty and Service

September 30, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » nform’s Breakthrough Oral Fluid Rapid Drug Tests Now Integrated into Origin One’s Occupational Health Platform
Press Release

nform’s Breakthrough Oral Fluid Rapid Drug Tests Now Integrated into Origin One’s Occupational Health Platform

By News RoomNovember 5, 20253 Mins Read
nform’s Breakthrough Oral Fluid Rapid Drug Tests Now Integrated into Origin One’s Occupational Health Platform
Share
Facebook Twitter LinkedIn Pinterest Email

JACKSONVILLE, Fla., Nov. 05, 2025 (GLOBE NEWSWIRE) — Origin One, an AI-powered occupational health platform, today announced its newest collaboration with nform, the creators of the only point-of-collection oral fluid screening devices for THC and other drugs that meet the strict U.S. Department of Transportation (US DOT) oral fluid laboratory screening standards for sensitivity and specificity.

The partnership brings together Origin One’s advanced digital workflow capabilities with nform’s pioneering diagnostic technology, enabling employers, third-party administrators (TPAs), and clinics to streamline drug screening processes from start to finish. The nform technologies are designed to detect recent drug use with exceptional accuracy, and can be easily deployed across decentralized testing sites, delivering lab-quality screening results in real time.

Origin One’s occupational health platform supports test scheduling, guided collection workflows, paperless chain of custody, reflex laboratory confirmation testing, and medical review for nform-enabled screening programs. Integration across mobile and desktop devices allows deployment in both traditional collection sites and decentralized test environments. The platform provides users with a powerful digital infrastructure and the flexibility to select preferred products, laboratories, and Medical Review Officer (MRO) services. The company’s recent advancements in digitizing the screening process further streamline every part of testing, delivering greater accuracy, speed, and efficiency to occupational health.

“As a diagnostic device company, we are ultimately in the business of delivering accurate and timely information,” said Michael Vincent, Chief Executive Officer of nform. “The partnership with Origin One is particularly exciting, as it ensures that otherwise standalone testing data is easily captured, made portable, and kept secure. This empowers organizations to make critical decisions in the moment, with unmatched confidence in analytical testing results and traceability. We are proud to be partnering with Origin One, a like-minded innovator in the industry.”

“nform and Origin One are trailblazers in their respective industries, working to address the need for more modern, integrated, and efficient occupational health solutions,” said Brian Weiner, Co-Founder and CEO of Origin One. “Legacy occupational health systems were built for analog-era workplaces and are outdated in a digital economy. Our collaboration with nform underscores our commitment to deliver smarter, faster, and more connected solutions that operate at the speed and precision our client’s demand.”

About nform

Founded in 2021, nform’s mission is to accelerate innovation within the in-vitro diagnostics field through the development of leading rapid diagnostic tests for drug detection in oral fluid. Its proprietary technologies are the first to meet the stringent U.S. DOT laboratory drug screening standards for sensitivity and specificity. By empowering organizations with accurate, actionable information at the point of collection—without waiting days for lab results—nform enables faster decision-making, improved safety, and better user experiences. For more information, visit www.nform.co.

About Origin One

Origin One is an AI-powered occupational health platform that helps TPAs, clinics, laboratories, MROs, and employers streamline screenings, digitize workflows, and eliminate paper. Built to modernize every aspect of occupational health for every stakeholder, Origin One replaces outdated, paper-heavy processes with a fully digital, customizable, and connected experience. By simplifying complexity and improving transparency, Origin One is reinventing occupational health for a smarter, faster, and more human-centered future. Learn more at www.originone.ai.

Media Contact:  Jay Adams
[email protected] 

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/c25ea8c7-5948-4102-9bc6-65865024a05f

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

Zhang Turan Returns to London as SUNCUN Completes Four-City Fashion-Week Journey

Apeing Announces Stage 5 Presale Milestone as $APEING Sales Surpass 476 Million Tokens

China Unicom Europe Marks 20th Anniversary in London with AI and Mid-Autumn Showcase

281M $APEING Tokens Burned as Solana Pullback Draws Attention to Emerging Crypto Projects

A Century of Integration, Loyalty and Service

Terumo Neuro Signs Agreement to Acquire Arsenal Medical – Advancing Next-Generation Liquid Embolic Innovation for Treating Chronic Subdural Hematoma (cSDH)

Kalmar wins preventive and corrective maintenance contract for STS and ASC cranes at TTI Algeciras

China Telecom Unveils TeleOCR: Lightweight 1.2B Model Tops Global Document Parsing Benchmarks

Sun Mountain Partners, a Shareholder of Ashtead Technology, Urges the Board to Reject Ember’s 615p Proposal

Editors Picks

Apeing Announces Stage 5 Presale Milestone as $APEING Sales Surpass 476 Million Tokens

September 30, 2026

China Unicom Europe Marks 20th Anniversary in London with AI and Mid-Autumn Showcase

September 30, 2026

281M $APEING Tokens Burned as Solana Pullback Draws Attention to Emerging Crypto Projects

September 30, 2026

A Century of Integration, Loyalty and Service

September 30, 2026

Latest News

Terumo Neuro Signs Agreement to Acquire Arsenal Medical – Advancing Next-Generation Liquid Embolic Innovation for Treating Chronic Subdural Hematoma (cSDH)

September 30, 2026

Kalmar wins preventive and corrective maintenance contract for STS and ASC cranes at TTI Algeciras

September 30, 2026

China Telecom Unveils TeleOCR: Lightweight 1.2B Model Tops Global Document Parsing Benchmarks

September 30, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version